Rogan Peter K, Svojanovsky Stan, Leeder J Steven
Laboratory of Human Molecular Genetics, Children's Mercy Hospital and Clinics, Kansas City, Missouri 64108, USA.
Pharmacogenetics. 2003 Apr;13(4):207-18. doi: 10.1097/00008571-200304000-00005.
Several mutations are known or suspected to affect mRNA splicing of CYP2C19, CYP2D6 and CYP3A5 genes; however, little experimental evidence exists to support these conclusions. The present study applies mathematical models that measure changes in information content of splice sites in these genes to demonstrate the relationship between the predicted phenotypes of these variants to the corresponding genotypes. Based on information analysis, the CYP2C192 variant activates a new cryptic site 40 nucleotides downstream of the natural splice site. CYP2C197 abolishes splicing at the exon 5 donor site. The CYP2D64 allele similarly inactivates splicing at the acceptor site of exon 4 and activates a new cryptic site one nucleotide downstream of the natural acceptor. CYP2D611 inactivates the acceptor site of exon 2. The CYP3A53 allele activates a new cryptic site 236 nucleotides upstream of the exon 4 natural acceptor site. CYP3A55 inactivates the exon 5 donor site and CYP3A56 strengthens a site upstream of the natural donor site, resulting in skipping of exon 7. Other previously described missense and nonsense mutations at terminal codons of exons in these genes affected splicing. CYP2D68 and CYP2D6*14 both decrease the strength of the exon 3 donor site, producing transcripts lacking this exon. The results of information analysis are consistent with the poor metabolizer phenotypes observed in patients with these mutations, and illustrate the potential value of these mathematical models to quantitatively evaluate the functional consequences of new mutations suspected of altering mRNA splicing.
已知或怀疑有几种突变会影响CYP2C19、CYP2D6和CYP3A5基因的mRNA剪接;然而,几乎没有实验证据支持这些结论。本研究应用数学模型来测量这些基因剪接位点信息含量的变化,以证明这些变体的预测表型与相应基因型之间的关系。基于信息分析,CYP2C192变体在天然剪接位点下游40个核苷酸处激活一个新的隐蔽位点。CYP2C197消除了外显子5供体位点的剪接。CYP2D64等位基因同样使外显子4受体位点的剪接失活,并在天然受体下游一个核苷酸处激活一个新的隐蔽位点。CYP2D611使外显子2的受体位点失活。CYP3A53等位基因在外显子4天然受体位点上游236个核苷酸处激活一个新的隐蔽位点。CYP3A55使外显子5供体位点失活,CYP3A56增强天然供体位点上游的一个位点,导致外显子7跳跃。这些基因外显子末端密码子处其他先前描述的错义突变和无义突变也影响剪接。CYP2D68和CYP2D6*14均降低了外显子3供体位点的强度,产生缺少该外显子的转录本。信息分析结果与这些突变患者中观察到的代谢不良表型一致,并说明了这些数学模型在定量评估怀疑改变mRNA剪接的新突变的功能后果方面的潜在价值。